Xiamen YST Biotech Co. Ltd.(Xiamen YST), a newly founded biotech company in Xiamen,China, is focusing on developing, manufacturing and marketing Innovative vaccines and diagnostic reagents.
    Our mission is providing the world community with the newest diagnostic regents, therapeutic products and novel vaccines for disease prevention and controls. We are committed to conduct research and development of human vaccines with the most advanced biotechnology and management procedures.
    In collaboration with the National Institute of Diagnostics and Vaccine Development in infectious diseases of Xiamen University (NIDVD), since 1999, we have achieved unique advantage in producing vaccine based on E.coli expression platform. Several products has been successfully developed.

Products name	Status	Description
Hepatitis E vaccine	phase III clinical trial	E.coli expressed
Bivalent HPV vaccine	in registration	E.coli expressed, against HPV 16/18
Quadrivalent HPV vaccine	late pre-clinic status	E.coli expressed, against HPV 6/11/16/18
AIV therapeutic monoclonal antibody	late pre-clinic status	A universal mouse Mab against AIV (H5 subtype)